BRIEF published on 05/14/2024 at 22:40, 1 year 9 months ago First 5 Network Challenges California's Proposed State Budget Cuts California Budget Cuts Child Services First 5 Network Medi-Cal Eligibility Early Childhood Education
BRIEF published on 05/14/2024 at 22:40, 1 year 9 months ago Les cinq premiers réseaux remettent en question les réductions budgétaires proposées par l'État de Californie Coupes Budgétaires En Californie Services À L'enfance Premier Réseau 5 Éligibilité Médicale L'éducation De La Petite Enfance
BRIEF published on 05/14/2024 at 22:26, 1 year 9 months ago Bausch Health Announces Updates on Norwich XIFAXAN Litigation and New FDA Submission XIFAXAN Bausch Health Patent Litigation FDA Submission Norwich Pharmaceuticals
BRIEF published on 05/14/2024 at 22:26, 1 year 9 months ago Bausch Health annonce des mises à jour sur le litige Norwich XIFAXAN et une nouvelle soumission à la FDA XIFAXAN Bausch Santé Contentieux Des Brevets Norwich Pharmaceutique Soumission À La FDA
BRIEF published on 05/14/2024 at 22:20, 1 year 9 months ago Sonnet BioTherapeutics Announces Fiscal Year 2024 Q2 Results and Business Updates Financial Results Clinical Trials Oncology Biopharmaceuticals Sonnet BioTherapeutics
BRIEF published on 05/14/2024 at 22:20, 1 year 9 months ago Sonnet BioTherapeutics annonce ses résultats du deuxième trimestre de l'exercice 2024 et des mises à jour sur ses activités Résultats Financiers Essais Cliniques Oncologie Sonnet BioTherapeutics Produits Biopharmaceutiques
BRIEF published on 05/14/2024 at 22:20, 1 year 9 months ago NANOBIOTIX Lance une Étude de Phase 2 sur le Traitement du Cancer du Poumon avec FDA Approval FDA Étude De Phase 2 NANOBIOTIX Cancer Du Poumon NBTXR3
BRIEF published on 05/14/2024 at 22:20, 1 year 9 months ago NANOBIOTIX Launches Phase 2 Lung Cancer Treatment Study with FDA Approval FDA Phase 2 Study NANOBIOTIX NBTXR3 Lung Cancer
BRIEF published on 05/14/2024 at 22:15, 1 year 9 months ago GENFIT Announces Q1 2024 Financials and Projects Cash Runway into Late 2025 Cash Position Clinical Trials Revenue Decline Biopharmaceutical Industry GENFIT Financial Results
BRIEF published on 05/14/2024 at 22:15, 1 year 9 months ago GENFIT annonce ses résultats financiers du premier trimestre 2024 et dispose d'une trésorerie disponible jusqu'à fin 2025 Industrie Biopharmaceutique Essais Cliniques Baisse Des Revenus Résultats Financiers De GENFIT Situation De Trésorerie
Published on 03/13/2026 at 23:00, 16 hours 19 minutes ago CORRECTION FROM SOURCE: EV Nickel Announces Maiden Mineral Resource Estimate for Gemini North Nickel Zone
Published on 03/13/2026 at 23:00, 16 hours 19 minutes ago Redwood AI Announces Platform Name Change and Appointment of Dr. Mark Dybul as Public Safety & Defense Advisor
Published on 03/13/2026 at 21:30, 17 hours 49 minutes ago Alset AI Announces Closing of Shares for Debt Transaction
Published on 03/13/2026 at 17:20, 21 hours 59 minutes ago Tocvan Partners With VRIFY to Accelerate Exploration and Enhance Discovery Potential With AI at Gran Pilar
Published on 03/13/2026 at 14:00, 1 day 1 hour ago CCL Industries Signs Agreement to Acquire Sleever International
Published on 03/14/2026 at 10:25, 4 hours 53 minutes ago Rendeavour and Wellington College Education to open global British School in Tatu City, Kenya
Published on 03/13/2026 at 21:53, 17 hours 25 minutes ago Mutares signs agreement to sell Relobus to Infracapital
Published on 03/13/2026 at 19:11, 20 hours 8 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/13/2026 at 19:00, 20 hours 19 minutes ago Notice of extraordinary general meeting of Brödernas Group AB
Published on 03/13/2026 at 20:30, 18 hours 49 minutes ago ALTAREA : MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2025
Published on 03/13/2026 at 20:30, 18 hours 49 minutes ago ALTAREIT : MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2025
Published on 03/13/2026 at 19:50, 19 hours 28 minutes ago Modalités de mise à disposition du Document d’Enregistrement Universel 2025 d’ENGIE
Published on 03/13/2026 at 19:50, 19 hours 28 minutes ago Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 21 hours 14 minutes ago Availability of the 2025 Universal Registration Document of OPmobility SE
